[HTML][HTML] Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy

N Krawczyk, BD Rivera, E Levin… - The Lancet Public …, 2023 - thelancet.com
As the USA faces a worsening overdose crisis, improving access to evidence-based
treatment for opioid use disorder (OUD) remains a policy priority. Federal regulatory …

Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among Medicare beneficiaries before and …

CM Jones, C Shoff, K Hodges, C Blanco… - JAMA …, 2022 - jamanetwork.com
Importance Federal emergency authorities were invoked during the COVID-19 pandemic to
expand use of telehealth for new and continued care, including provision of medications for …

The impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on substance use in the United States

JA Ross, PK Malone, S Levy - Clinical Infectious Diseases, 2022 - academic.oup.com
The SARS-CoV-2 pandemic has been associated with dramatic increases in substance use,
as marked by increased alcohol, nicotine, and cannabis sales. Lethal opioid overdoses also …

[HTML][HTML] Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives

SV Aronowitz, E Engel-Rebitzer, A Dolan… - Harm reduction …, 2021 - Springer
Background The majority of individuals with opioid use disorder (OUD) face access barriers
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …

Assessment of community-level vulnerability and access to medications for opioid use disorder

PJ Joudrey, M Kolak, Q Lin, S Paykin… - JAMA Network …, 2022 - jamanetwork.com
Importance Given that COVID-19 and recent natural disasters exacerbated the shortage of
medication for opioid use disorder (MOUD) services and were associated with increased …

“The idea is to help people achieve greater success and liberty”: A qualitative study of expanded methadone take-home access in opioid use disorder treatment

LW Suen, S Castellanos, N Joshi… - Substance …, 2022 - journals.sagepub.com
Background: Prior to the COVID-19 pandemic, the United States (US) was already facing an
epidemic of opioid overdose deaths. Overdose deaths continued to surge during the …

Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis

SA Kitchen, TJ Campbell, S Men, N Bozinoff… - International Journal of …, 2022 - Elsevier
Abstract Background In March 2020, the Ontario government declared a state of emergency
due to the growing risk of COVID-19. In response, new guidance for the management of …

Article Commentary: Research Priorities for Expanding access to Methadone Treatment for Opioid use Disorder in the United States: A National Institute on Drug …

PJ Joudrey, G Bart, RK Brooner, L Brown… - Substance …, 2021 - journals.sagepub.com
In the US, methadone treatment can only be provided to patients with opioid use disorder
(OUD) through federal and state-regulated opioid treatment programs (OTPs). There is a …

Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations

C Welsh, S Doyon, K Hart - International Journal of Drug Policy, 2022 - Elsevier
Background Methadone is a highly effective treatment for opioid use disorder. Its use in the
United States is highly regulated at both the federal and state level. The regulations related …

[HTML][HTML] Trends in engagement with opioid use disorder treatment among Medicaid beneficiaries during the COVID-19 pandemic

AS Tilhou, L Dague, B Saloner, D Beemon… - JAMA Health …, 2022 - jamanetwork.com
Importance Disruptions in care during the COVID-19 pandemic may have decreased access
to care for patients with opioid use disorder. Objective To examine trends in opioid use …